ExcellGene is currently owned by ARCHIMED, through MED Rise, since 2025.

When did ARCHIMED acquire ExcellGene?

ARCHIMED acquired ExcellGene in 2025 (active for 1 year).

Home/Companies/Biotech/ExcellGene

ExcellGene

Biotech·

Switzerland·Active·1yr hold

ExcellGene is a life science tools & biologic services company, headquartered in Switzerland.

Entry

2025

Hold

1yr

Status

Active

Est. EV

–

Investor

ARCHIMED

Key facts

HQSwitzerland

SectorLife Science Tools & Biologic Services

Founded in 2001 in Monthey, Switzerland, ExcellGene is a family-owned pioneer in cell line development and cell culture-based manufacturing…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from MED Rise

Other portfolio companies in the same fund.

More PE-backed in Biotech

Comparable biotech deals from other GPs.

AdBio PartnersBelgium

Last updated April 2026 · Sourced from public filings